Retatrutide

Price range: ₱3,998.00 through ₱7,498.00
Select options This product has multiple variants. The options may be chosen on the product page
Retatrutide is an emerging triple hormone receptor agonist (GIP, GLP-1, and glucagon receptors), currently in clinical trials for treating obesity, type 2 diabetes, and metabolic disorders. It’s considered a next-generation weight loss drug—potentially more effective than both semaglutide and tirzepatide.

Tirzepatide

Price range: ₱3,498.00 through ₱6,998.00
Select options This product has multiple variants. The options may be chosen on the product page
Tirzepatide is a dual GIP and GLP-1 receptor agonist—a new class of medication used primarily for type 2 diabetes and obesity. Here’s a comprehensive list of the benefits of Tirzepatide, based on current clinical data: